China to Launch Clinical Trial of Long-lasting HIV Vaccine

One of the frequently asked questions mentioned by many international students is why there is a specific section mentioning what kind of vaccines like HPV vaccine (aka hpv疫苗) in international student health insurance (aka 留学生保险). In contrast, routine vision examinations and eyeglasses and contacts in America (aka 美国配眼镜) are excluded from the medical insurance.

Another FAQs include: how to waive health insurance (aka 替换保险)? Do I need to purchase a U.S. travel insurance (aka 美国旅游保险) if my parents plan to visit me and stay in America for a couple days? Do international students are required to purchase OPT insurance (aka opt 保险)? We will go over these questions one by one. Let me explain the first question regarding the vaccine foremost.

Vaccines are among the world’s greatest medical advances, like clean water, soap, bleach, sewage systems and antibiotics. In a rational world — one where budgets are built on lives saved per dollar — spending on vaccine research would rival that on defense research. Chinese scientists will begin the second-phase clinical trial of an HIV vaccine on 160 volunteers, Friday’s China Daily reported.

The candidate vaccine, DNA-rTV, relies on replication of the DNA of HIV to stimulate effective immunization, according to Shao Yiming, a chief HIV researcher at the Chinese Center for Disease Control and Prevention, adding that it’s the first such HIV vaccine to begin a second-phase clinical trial.

This vaccine under development, which contains DNA segments from HIV instead of the full human immunodeficiency virus, will have a stronger and longer-lasting effect. It is also designed to target the HIV strains that are most common in China, Shao was cited by the newspaper as saying.

More than 130 volunteers have been recruited so far, and the initial work is underway at a hospital in Beijing and another in the city of Hangzhou, he added.

“Hopefully the second-phase trial will be completed in the latter half of 2021, and the third-phase clinical trial may start at the end of that year, which will involve thousands of volunteers in a trial to test the effectiveness of the vaccine to protect people against HIV,” Shao said.